Bariatric Surgery Today: How It’s Saving Lives Beyond Weight Loss

There is a serious gap in how healthcare works in India. The country has one of the world’s largest numbers of people with diabetes, second only to China in International Diabetes Federation estimates.^[1] At the same time, metabolic disorders are rising rapidly.^[2] Additionally, another growing concern is sarcopenic obesity, where people have high body fat but low muscle mass.

In many cases, these patients look normal from the outside. Their weight appears healthy. However, their internal health tells a very different story. As a result, many serious problems go unnoticed.

South Asians tend to carry more visceral fat than Europeans of the same BMI, so BMI can underestimate it.^[3] At the same time, muscle mass declines with age.^[4] Nutritional deficiencies, such as vitamin D deficiency, are also common.^[5] In addition, many patients do not follow up regularly. Because of all this, traditional methods can fail to give a complete picture.

This is where InBody body composition analysis becomes important. It uses advanced Bioelectrical Impedance Analysis (BIA). This method gives a detailed view of fat, muscle, and water in the body. As a result, doctors can understand a patient’s real health status.

The test is quick and simple. It takes less than 60 seconds. Independent studies in healthy adults report that InBody analysers estimate fat and lean mass reasonably well compared with DEXA, although systematic differences exist.^[6][7] Therefore, it can support diagnosis and treatment planning.

THE INDIA-SPECIFIC PROBLEM:

A WHO expert consultation concluded that a substantial proportion of Asians are at high risk of type 2 diabetes and cardiovascular disease at BMIs below 25. It added public-health action points at BMI 23.0 and 27.5 but kept the international 25 and 30 cut-offs.^[8] Indian consensus guidelines define overweight as BMI 23–24.9 and obesity as BMI ≥25.^[9] However, BMI alone can still miss some Indians with “normal weight obesity”, a normal or low BMI masking high body fat and visceral fat. Fortunately, InBody can help identify these patients in about 60 seconds.

Why Standard Screening Fails the Indian Body

Clinical tools such as BMI and waist circumference were largely developed on Western populations, and Asian populations have different associations between BMI, body fat percentage, and health risk than Europeans.^[8] Consequently, their reference ranges and thresholds may be calibrated on bodies with different fat distribution patterns, different muscle mass norms, and different metabolic trajectories than the South Asian body.

The Thin-Fat Indian Phenomenon

Research by Professor C.S. Yajnik and colleagues at KEM Hospital, Pune described the “thin-fat Indian” phenotype, first in newborns: Indian babies were small with low muscle mass but relatively preserved body fat.^[10] The term is now used for people who look lean but carry relatively high body fat, including around the organs. At a given BMI, body fat tends to be higher in Indians than in Western populations.^[11][12][3]

Studies in Indian adults report a similar pattern: in a DXA study of 2,347 Indian adults, body fat was higher than in Western populations for a given age and BMI.^[11] As a result, some Indians may face health risks at lower BMI levels than expected.^[8]

For example, Indian patients may develop insulin resistance, metabolic syndrome, and Type 2 diabetes at lower body weights. They are also at risk even at lower BMI levels compared to Western standards.^[8]

In other words, a BMI of 24 may look “healthy” by the international WHO classification. However, in Indian adults it can still coincide with high body fat: in one DXA study, 25% body fat in men and 30% in women corresponded to a BMI of about 22.^[11]

CLINICAL ALERT FOR INDIAN PRACTITIONERS:

Using a BMI cut-off of 30 to screen for obesity in Indian patients can miss people with clinically significant visceral adiposity and metabolic risk.^[8] In addition, the Indian consensus cut-off for obesity is BMI ≥25 (WHO’s public-health action points are 23.0 and 27.5), but even these may be insufficient for individual patient assessment without body composition data.^[8][9]

Muscle Loss: A Hidden Crisis

Low muscle mass alongside excess body fat is a growing concern in India. It is not limited to older adults. Low-quality protein intake (almost 60% of protein in Indian diets comes from cereals, which have relatively low digestibility and quality),^[13] inactive lifestyles, rapid urbanisation, and low awareness about nutrition are thought to contribute. As a result, some people develop sarcopenia (low muscle mass) and dynapenia (low muscle strength).

Skeletal muscle plays an important role in controlling blood sugar. Under insulin-stimulated conditions, it accounts for about 80% of glucose uptake.^[14] Therefore, low muscle mass is associated with greater insulin resistance and a higher prevalence of prediabetes, even after adjusting for overall and central obesity (US NHANES III data).^[15]

In addition, people with both low muscle and high fat (sarcopenic obesity) are a recognised high-risk group, particularly in older adults.^[16] This combination is often hidden and cannot be detected by weight alone. Body composition analysis can show this problem much more clearly.

KEY INSIGHT:

In many Indian patients, the metabolic problem is dual: too much fat and too little muscle. BMI captures neither. InBody estimates fat and muscle mass, shows how they are distributed segmentally, and reports the ECW/TBW ratio, a fluid-balance marker.^[17]

What InBody Actually Measures and Why It Matters for Indian Patients

InBody uses Direct Segmental Multi-frequency Bioelectrical Impedance Analysis (DSM-BIA) applying alternating electrical currents at up to 6 frequencies (1, 5, 50, 250, 500, 1000 kHz) independently through each of five body segments: right arm, left arm, trunk, right leg, and left leg. The result is a granular, segment-specific body composition profile that no scale or BMI formula can provide.

InBody & Diabetes Management in India: The Clinical Evidence

India’s diabetes epidemic is not simply a problem of excess weight. It is also a problem of body composition: visceral fat is linked to insulin resistance,^[18] too little skeletal muscle reduces the body’s capacity to clear glucose,^[14][15] and the ECW/TBW ratio can flag fluid imbalance in some patients.

Consequently, InBody can measure all three dimensions in a single scan. Some clinicians in India use InBody as a risk-assessment aid, a treatment-monitoring tool, and a patient engagement device. Specifically, the visual, personal nature of the result sheet can help support patient engagement and follow-up.

Illustrative Case Study 1

The Prediabetic Professional: Mumbai, Age 42

A 42-year-old software professional in Mumbai presented with HbA1c of 6.1% (prediabetic range),^[19] BMI of 24.8 (classified “healthy” by standard criteria), and mild hypertension. Standard screening had not flagged him for active intervention. This is an illustrative, unpublished example, not drawn from a published study; individual results vary.

An InBody 770 scan revealed: Visceral Fat Level 13 (above InBody’s level-10 risk threshold)^[17], Body Fat Percentage 34.2% (high), Skeletal Muscle Mass 3.2 kg below population norm for his age and height, and ECW/TBW ratio of 0.396 (above InBody’s 0.390 reference limit, which can reflect fluid imbalance).

Based on these findings, a targeted 16-week programme of structured resistance training, a protein-adequate diet, and an 8,000-step daily target was designed specifically around his InBody results. By the end of 16 weeks, his body composition scan showed the following changes.

What this example illustrates:

Standard screening can under-identify the risk, and standard weight-loss advice can under-target the intervention. Body composition data can help clinicians target treatment more precisely.
For diabetes management in India, the analysis includes Visceral Fat Level, Skeletal Muscle Mass, ECW/TBW ratio, and segmental Body Fat Percentage.
These indicators give clinicians a picture of fat distribution, muscle mass and fluid balance to use alongside blood tests, all delivered on a single result sheet in under 60 seconds.

InBody in Bariatric & Metabolic Surgery: The Apollo Hospital Experience

According to an account published by InBody India, Dr. Raj Palaniappan, Director and Lead Bariatric Surgeon at Apollo Hospital, Chennai, has observed a major shift in bariatric care in India. Today, it is not just about weight loss. It is about treating metabolic health.

By 2019, according to the same account, most of his patients (around 80%, a figure reported by InBody India and not independently verified) had conditions like metabolic syndrome, diabetes, high blood pressure, and abnormal cholesterol levels. In other words, most patients were not just obese. They had deeper health issues.

At this point, tools like InBody became important. InBody is a scientific method of body composition analysis. It helps doctors understand what is happening inside the body, beyond just weight.

— Dr. Raj Palaniappan, Director & Lead Bariatric Surgeon, Apollo Hospital, Chennai

InBody helps solve three key challenges in Indian bariatric patients:

First, pre-surgery risk assessment.

InBody can estimate muscle mass before surgery, which may help flag patients with very low muscle mass. Fat-free mass loss is a recognised concern after bariatric surgery,^[20][21] so these patients may need closer monitoring and preparation. This can include a protein-adequate diet and resistance training before surgery (supervised exercise before surgery improves body composition and function, but there is no evidence yet on surgical outcomes).^[22]

Second, post-surgery muscle monitoring.

After bariatric surgery, fat-free mass (which includes muscle) is lost along with fat, mostly within the first 3 to 6 months, and in a meta-analysis of four trials about one-third (34%) of total weight lost was fat-free mass.^[20][21] Because of this, regular InBody scans can help track muscle change. Clinics often schedule follow-up at about 1, 3, 6, and 12 months, which gives a chance to detect muscle loss early and take action.

Third, improving patient compliance.

One of the biggest challenges after surgery is that patients do not always follow medical advice. However, showing patients their own body composition data may help. When they see clear, visual results, they may understand their progress better. As a result, they may be more likely to follow diet and exercise plans.

Case Example 2 (published by InBody India)

Post-Bariatric Muscle Preservation: Chennai, Age 38

A 38-year-old woman in Chennai underwent a sleeve gastrectomy for metabolic syndrome (BMI 36, T2DM, hypertension). Pre-operative InBody 770 scan revealed skeletal muscle mass 4.8 kg below norm for her height, flagging her as high-risk for post-surgical sarcopenia. This case is as published by InBody India and attributed to the practice of Dr. Raj Palaniappan at Apollo Hospital, Chennai; it is a single, non-peer-reviewed case report. Its fat-versus-muscle split is better than the average reported in the studies cited above, and individual results vary.

In response, a 6-week pre-habilitation programme was initiated: 30g protein supplement twice daily and supervised resistance training three times per week. As a result, her SMM increased by 1.8 kg before surgery. Subsequently, post-operative quarterly InBody scans guided a graduated return to protein targets and a progressive resistance programme.

InBody in Indian Sports & Elite Athletic Conditioning

In sport, from cricket and athletics programmes to the emerging Indian fitness industry, body composition is increasingly monitored as a performance variable, and InBody is one of the tools used for this. Body composition is one of several performance variables alongside speed, strength, and endurance.

What InBody Provides for Indian Athletes

For elite Indian athletes, the standard sports science challenge is maximising muscle mass while minimising fat, tracking recovery from injury, and monitoring the composition effects of nutrition periodisation across a competitive season. In addition, InBody provides segment-level data, for instance, allowing coaches and physios to identify left-right limb muscle asymmetry that may be relevant to injury risk, or a decrease in trunk lean mass that may signal inadequate recovery nutrition.

SPORTS PERFORMANCE: InBody segmental lean analysis reports muscle mass for each arm and leg separately, so right-left differences can be tracked over time. For example, for cricketers and tennis players, tracking bowling-arm vs non-bowling-arm differences may help coaches plan targeted conditioning.

InBody for Elderly Indian Patients & the Sarcopenia Crisis

India’s population of adults over 60 is projected to reach 347 million by 2050.^[23] The combination of age-related muscle loss (sarcopenia), diets that are often low in protein quality,^[13] sedentary urbanised lifestyles, and low awareness of strength training can raise the risk of loss of functional independence, falls, fracture, and metabolic deterioration in India’s ageing population.

The Asian Working Group for Sarcopenia (AWGS 2019) defines low muscle mass, by bioimpedance, as appendicular skeletal muscle mass divided by height squared (SMI) below 7.0 kg/m² in men and 5.7 kg/m² in women (5.4 kg/m² when measured by DXA); sarcopenia is diagnosed when low muscle mass accompanies low muscle strength or low physical performance.^[24] InBody reports a Skeletal Muscle Index directly and quickly. Notably, the AWGS uses cut-offs developed for Asian populations rather than Western ones.^[24]

MONITORING APPROACH FOR ELDERLY INDIAN PATIENTS:
One practical approach for patients over 60 is a baseline scan followed by repeat scans about every six months (a suggestion, not a guideline). Focus markers: Skeletal Muscle Index (SMI), Segmental Lean Analysis (watching for a leg muscle deficit), ECW/TBW ratio (above InBody’s 0.390 reference limit can reflect fluid imbalance and should be interpreted by a clinician),^[17] and InBody Score trajectory over time.

InBody in Corporate Wellness India

Sedentary office work and stress-related eating are common concerns in India’s IT, banking, and professional services sectors. Corporate wellness programmes that rely only on annual medical check-ups with BMI and blood panels may miss markers, such as visceral fat and muscle mass, that help identify who is at higher risk of diabetes, metabolic syndrome, or cardiovascular disease.^[18]

Some employers, including IT campuses, financial institutions, and pharmaceutical companies, use InBody scanning in their annual health assessments. Because BMI cannot separate fat from muscle or show where fat is stored, some employees classified as “healthy” by BMI alone may have body composition profiles that warrant clinical attention.^[3]

WORKPLACE SCREENING: Body composition screening in workplace programmes can help identify employees with a normal BMI but a high visceral fat level. Subsequently, these employees can be offered targeted lifestyle support.

What Results Can Indian Patients Realistically Expect?

InBody does not produce results on its own. Rather, it gives patients and clinicians specific data, such as visceral fat level, muscle deficit, and the ECW/TBW ratio, that can inform decisions about diet, exercise, and follow-up. In contrast, a weight and a BMI alone show far less of the picture.

The table below summarises what published studies suggest for each context. Most of the studies cited are not InBody-specific or India-specific, and individual results vary. All results assume structured dietary and/or exercise interventions; InBody is the measurement tool that enables targeting and tracking, not an intervention in itself.

InBody in Clinical, Sports and Wellness Settings Across India

InBody is used in a range of clinical, sports, and wellness settings in India. Typical contexts include:

• Bariatric & metabolic surgery: Apollo Hospital Chennai (according to InBody India): pre-operative assessment, post-operative monitoring, nutritional rehabilitation.
• Endocrinology & diabetes clinics: Diabetes management programmes: visceral fat tracking, muscle-mass monitoring, patient engagement.
• Sports medicine & conditioning: Team conditioning programmes, athletics camps, and sports-science departments.
• Geriatric medicine: Sarcopenia screening programmes, fall prevention clinics, frailty assessment in elderly Indian patients.
• Oncology nutrition support: Monitoring muscle preservation and nutritional status in cancer patients undergoing chemotherapy, where muscle mass may be relevant to treatment tolerance.
• Corporate health assessment: Annual health check integration in corporate settings such as IT campuses, banks, and pharmaceutical companies.

Key Takeaways: The Scientific Power of InBody for Indian Patients

• Standard BMI and blood tests can under-detect metabolic risk in Indian patients. The thin-fat Indian phenotype, with high visceral fat at normal BMI, is not visible on BMI alone and needs body composition analysis to identify.
• InBody provides 8 clinically relevant markers in under 60 seconds: visceral fat, muscle mass, body fat %, ECW ratio, segmental lean analysis, trunk fat, android/gynoid ratio, and InBody Score, all relevant to Indian patients.
• For diabetes management, InBody measures two key correlates of T2DM risk, visceral fat and low muscle mass, and can track their response to interventions, which blood tests alone do not show.
• In bariatric care, it helps monitor muscle loss, can inform post-operative nutrition, and may support patient engagement through personalised body composition data.
• Within sports medicine, segmental lean analysis can show limb asymmetry and help monitor training periodisation, which simple weight measurements cannot reveal.
• Structured diet and exercise programmes can reduce visceral fat and build or preserve muscle; InBody is the measurement tool used to track that change, and individual results vary.

Frequently Asked Questions

See What Standard Tests Are Missing in Your Body

An InBody scan takes under 60 seconds and reveals the body composition data your doctor needs to give you truly personalised, evidence-based care.

Find an InBody Scanner Near You

References

1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. PubMed · DOI
2. Anjana RM, Unnikrishnan R, Deepa M, Pradeepa R, Tandon N, Das AK, et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17). Lancet Diabetes Endocrinol. 2023;11(7):474-489. PubMed · DOI
3. Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham CL. Visceral adipose tissue accumulation differs according to ethnic background: results of the Multicultural Community Health Assessment Trial (M-CHAT). Am J Clin Nutr. 2007;86(2):353-359. PubMed · DOI
4. Kim TN, Choi KM. Sarcopenia: definition, epidemiology, and pathophysiology. J Bone Metab. 2013;20(1):1-10. PubMed · DOI
5. G R, Gupta A. Vitamin D deficiency in India: prevalence, causalities and interventions. Nutrients. 2014;6(2):729-775. PubMed · DOI
6. McLester CN, Nickerson BS, Kliszczewicz BM, McLester JR. Reliability and agreement of various InBody body composition analyzers as compared to dual-energy X-ray absorptiometry in healthy men and women. J Clin Densitom. 2020;23(3):443-450. PubMed · DOI
7. Anderson LJ, Erceg DN, Schroeder ET. Utility of multifrequency bioelectrical impedance compared with dual-energy x-ray absorptiometry for assessment of total and regional body composition varies between men and women. Nutr Res. 2012;32(7):479-485. PubMed · DOI
8. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157-163. PubMed · DOI
9. Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India. 2009;57:163-170. PubMed
10. Yajnik CS, Fall CH, Coyaji KJ, Hirve SS, Rao S, Barker DJ, et al. Neonatal anthropometry: the thin-fat Indian baby. The Pune Maternal Nutrition Study. Int J Obes Relat Metab Disord. 2003;27(2):173-180. PubMed · DOI
11. Marwaha RK, Tandon N, Garg MK, Narang A, Mehan N, Bhadra K. Normative data of body fat mass and its distribution as assessed by DXA in Indian adult population. J Clin Densitom. 2014;17(1):136-142. PubMed · DOI
12. Deurenberg-Yap M, Schmidt G, van Staveren WA, Deurenberg P. The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes Relat Metab Disord. 2000;24(8):1011-1017. PubMed · DOI
13. Swaminathan S, Vaz M, Kurpad AV. Protein intakes in India. Br J Nutr. 2012;108(Suppl 2):S50-S58. PubMed · DOI
14. DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;32(Suppl 2):S157-S163. PubMed · DOI
15. Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab. 2011;96(9):2898-2903. PubMed · DOI
16. Prado CM, Batsis JA, Donini LM, Gonzalez MC, Siervo M. Sarcopenic obesity in older adults: a clinical overview. Nat Rev Endocrinol. 2024;20(5):261-277. PubMed · DOI
17. InBody Co., Ltd. Result Sheet Interpretation (parameter keynote; ECW Ratio and Visceral Fat Level reference ranges). InBody Research, accessed 1 October 2026. Manufacturer document, not peer-reviewed. research.inbody.com
18. Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019;7(9):715-725. PubMed · DOI
19. Centers for Disease Control and Prevention. Diabetes Testing (A1C result ranges). CDC, accessed 1 October 2026. cdc.gov
20. Nuijten MAH, Monpellier VM, Eijsvogels TMH, Janssen IMC, Hazebroek EJ, Hopman MTE. Rate and determinants of excessive fat-free mass loss after bariatric surgery. Obes Surg. 2020;30(8):3119-3126. PubMed · DOI
21. Busk-Cirera L, Carlsen IØ, Madsen LB, Sandsdal RM, Jensen E, Jensen SBK, et al. Effects of incretin-based therapies, diet and exercise interventions, and bariatric surgery on fat-free mass in adults with overweight or obesity: a systematic review and meta-analysis. Diabetes Obes Metab. 2026;28(9):7737-7751. PubMed · DOI
22. Herrera-Santelices A, Argüello-Florencio G, Westphal G, Nardo Junior N, Zamunér AR, et al. Effects of supervised physical exercise as prehabilitation on body composition, functional capacity and quality of life in bariatric surgery candidates: a systematic review and meta-analysis. J Clin Med. 2022;11(17):5091. PubMed · DOI
23. UNFPA India. India’s ageing population: why it matters more than ever. UNFPA India, 23 December 2023 (reporting the UNFPA/IIPS India Ageing Report 2023: 347 million people aged 60+ by 2050). india.unfpa.org
24. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300-307.e2. PubMed · DOI
25. Vissers D, Hens W, Taeymans J, Baeyens JP, Poortmans J, Van Gaal L. The effect of exercise on visceral adipose tissue in overweight adults: a systematic review and meta-analysis. PLoS One. 2013;8(2):e56415. PubMed · DOI
26. Morton RW, Murphy KT, McKellar SR, Schoenfeld BJ, Henselmans M, Helms E, et al. A systematic review, meta-analysis and meta-regression of the effect of protein supplementation on resistance training-induced gains in muscle mass and strength in healthy adults. Br J Sports Med. 2018;52(6):376-384. PubMed · DOI
27. Liu CJ, Latham NK. Progressive resistance strength training for improving physical function in older adults. Cochrane Database Syst Rev. 2009;(3):CD002759. PubMed · DOI